which then potently suppressed inflammation in this mouse model of neutrophilic asthma. More information: Vijay Raaj Ravi et al, Lung CD4+ resident memory T cells use airway secretory cells to ...
New therapeutic "cocktails" could offer long-lasting relief for treatment-resistant asthma and other inflammatory diseases of ...
which then potently suppressed inflammation in this mouse model of neutrophilic asthma.
The researchers demonstrated that they could treat a mouse model of severe allergic asthma using either a combination of an ICOSL and OX40L inhibitor—or an ICOSL and CD30L inhibitor. The ...
1don MSN
A new study by UCLA Health has discovered what researchers say is the first drug to fully reproduce the effects of physical ...
Asthma is a heterogeneous disorder ... In conclusion, we demonstrate that TNFα reduces the responsiveness to GCs in a mouse model of neutrophilic airway inflammation. Thus antagonizing TNFα ...
The researchers demonstrated that they could treat a mouse model of severe allergic asthma using either a combination of an ICOSL and OX40L inhibitor-or an ICOSL and CD30L inhibitor. The ...
Rapid resolution of systemic anaphylactic reaction in a therapeutic mouse model. Reduction of serum IgE and eosinophils in bronchoalveolar lavage (BAL) in rat allergen-induced asthma model.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback